Apreo Health, Inc.: Early phase 1 study in Air Trapping, Emphysema (15 participants)
Apreo Health, Inc.: Early phase 1 study in Air Trapping, Emphysema (15 participants). Its enrollment of 15 is below the median of 80 (6th percentile). Dated 8 days ago, it is in the active follow-up window. Score 65/100. As of 2026-11-03, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 15 · 6th percentile of 8,570 ClinicalTrialStartPulse records · 0.2x the median
Free preview: all 14 published fields of this record are shown below. Locked: 499 related US ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Apreo Health, Inc. |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Xenon MRI to Evaluate Changes to Lung Function Following Bronchoscopic Treatment of Air Trapping in Emphysema |
| NCT ID | NCT07896902 |
| Phase | Early phase 1 |
| Status | recruiting |
| Conditions | Air Trapping; Emphysema; Hyperinflation |
| Intervention types | drug, device |
| Target enrollment | 15 |
| Site countries | United States |
| Posted | 2026-10-27 |
| Planned start | 2026-10 |
| Event | Newly registered study |
| Event date | 2026-10-27 |
| enrollment percentile | 6th of 8,570 (median 80, 0.2x median) |
| Peer records CSV (500 US records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Apreo Health, Inc.
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of US records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Apreo Health + 500 US peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-27
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (US first): Sanofi · Pfizer · National Institute of Arthritis and Musculoskeletal and Skin · Apple Inc. · National Cancer Institute (NCI) · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Tue, 03 Nov 2026 05:11:05 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Apreo Health, Inc. and 2,424 US peers
- US ClinicalTrialStartPulse records like this one: 2,424
- Apreo Health, Inc.'s enrollment: 6th percentile of 8,570 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every US peer: $484,800 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
65 / 100 Score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
What is the ClinicalTrialStartPulse record for Apreo Health, Inc.?
Apreo Health, Inc. registered a Early phase 1 study (NCT07896902) in Air Trapping targeting 15 participants, posted 2026-10-27.
How does Apreo Health, Inc. compare to other ClinicalTrialStartPulse records?
Its enrollment of 15 is below the median (6th percentile); smaller records often move faster and face less competition. It is fresh: dated 8 days ago, inside the window where early outreach matters most.
Apreo Health, Inc. vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Apreo Health, Inc. | US | 15 | 6th | 2026-10-27 |
| University of Wisconsin, Madison | US | 15 | 6th | 2026-10-23 |
| Mclean Hospital | US | 30 | 19th | 2026-10-30 |
| Yale University | US | 139 | 68th | 2026-11-02 |
Related records
- Applied Biology, Inc.
- Applied Biology, Inc.
- M.D. Anderson Cancer Center
- Rush University Medical Center
- Ohio State University
- Mclean Hospital
- University of Wisconsin, Madison
- Atridia Pty Ltd.
- Yale University
- Eye & ENT Hospital of Fudan University
- Olivia Newton-John Cancer Research Institute
- The First Affiliated Hospital with Nanjing Medical University
ClinicalTrialStartPulse: Early phase 1 ClinicalTrialStartPulse: United States sites
More US public-record feeds
U.S. DOT Injury/Illness Summary Pulse in US U.S. DOT FRA Regulated Mode Major Security Events Pulse in US U.S. DOT Crossing Inventory Data Pulse in US U.S. DOT Insur - All With History Pulse in US USAC Telecom CAF Locations Obligation and Deployment by Speed Tier Data Pul in US U.S. CDC 2022 Final Assisted Reproductive Technology Summary Pulse in US U.S. DOT Rail Equipment Accident/Incident Data Subset Pulse in US U.S. DOT Monthly Modal Time Series Pulse in US
How to monitor Apreo Health, Inc. and peer early phase 1 records
Get new ClinicalTrialStartPulse records like Apreo Health, Inc. by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.